Table 1. Characteristics and clinical features of the study participants#.
| Clinical features | ‘Definite’ ATB (n = 2) | ‘Probable’ ATB (n = 16) | ‘Possible’ ATB (n = 13) | ‘ATB’ group$ (n = 31) | ‘Non-TB’ group (n = 34) | p-value* |
|---|---|---|---|---|---|---|
| Male/Female (M%/F%) | 2/0 (100/0) | 6/10 (37.5/62.5) | 13/0 (100/0) | 21/10 (67.7/32.2) | 22/12 (64.7/35.2) | - |
| Fever | 2 (100) | 14 (87.5) | 8 (61.5) | 24 (77.4) | 10 (29.4) | 0.001 |
| Headache | 0 (0) | 1 (6.2) | 1 (7.6) | 2 (6.4) | 1 (2.94) | 0.601 |
| Vomiting | 2 (100) | 4 (25) | 5 (38.4) | 11 (35.4) | 8 (23.5) | 0.413 |
| Loss of appetite | 2 (100) | 11 (68.7) | 9 (69.2) | 21 (67.7) | 18 (52.9) | 0.311 |
| Constipation | 2 (100) | 7 (43.7) | 4 (30.7) | 13 (41.9) | 10 (29.4) | 0.312 |
| Diarrhoea | 0 (0) | 2 (12.5) | 1 (7.6) | 3 (9.6) | 2 (5.8) | 0.663 |
| Weight loss | 2 (100) | 10 (62.5) | 5 (38.4) | 17 (54.8) | 7 (20.5) | 0.005 |
| Night Sweats | 1 (50) | 2 (12.5) | 3 (23.0) | 6 (19.3) | 3 (8.8) | 0.290 |
| Abdominal distension | 0 (0) | 5 (31.2) | 3 (23.0) | 8 (25.8) | 2 (5.9) | 0.038 |
| Abdominal pain | 1 (50) | 11 (68.7) | 8 (61.5) | 20 (64.5) | 25 (73.5) | 0.591 |
| Cough | 1 (50) | 6 (37.5) | 4 (30.7) | 11 (35.4) | 9 (26.4) | 0.591 |
| Chest pain | 0 (0) | 3 (18.7) | 1 (7.6) | 4 (12.9) | 4 (11.7) | 1.000 |
| Haemoptysis | 0 (0) | 2 (12.5) | 2 (15.3) | 4 (12.9) | 1 (2.9) | 0.183 |
| Past history of TB | 0 (0) | 1 (6.2) | 1 (7.6) | 2 (6.4) | 1 (2.9) | 0.601 |
| History of TB contact | 1 (50) | 4 (25) | 4 (30.7) | 9 (29.0) | 7 (20.5) | 0.566 |
| Alcoholism | 1 (50) | 1 (6.2) | 5 (38.4) | 7 (22.5) | 15 (44.1) | 0.114 |
| Smoking | 0 (0) | 1 (6.2) | 5 (38.4) | 6 (19.3) | 5 (14.7) | 0.744 |
| Amenorrhea | 0 (0) | 5 (31.2) | 0 | 5 (16.1) | 4 (11.7) | 0.726 |
| Pallor | 2 (100) | 5 (31.2) | 5 (38.4) | 12 (38.7) | 13 (38.2) | 1.000 |
| Pedal edema | 0 (0) | 3 (18.7) | 2 (15.3) | 5 (16.1) | 8 (23.5) | 0.543 |
| Hepatomegaly | 1 (50) | 4 (25) | 3 (23.0) | 8 (25.8) | 7 (20.5) | 0.769 |
| Splenomegaly | 1 (50) | 1 (6.2) | 3 (23.0) | 5 (16.1) | 3 (8.8) | 0.463 |
| Positive Mantoux test^ | 1/2 (50) | 6/14 (42.8) | 2/8 (25.0) | 9/24 (37.5) | 1/17 (5.8) | 0.028 |
#values denoted as number of patients showing clinical signs in each category; values in brackets denotes the percentage of patients presenting the clinical features.
$ATB group includes ‘Definite’, ‘Probable’ and ‘Possible ATB’ categories collectively.
^Mantoux test data was available for n = 24 patients in ATB group and n = 17 patients in non-TB group.
*statistical significance calculated between ‘ATB’ group vs. Non-TB group by Fisher’s test, significant values (p-value < 0.05) are in bold.